Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsOrthopaedic Oncology & Bone TumorsChondrosarcoma of the Pelvis and Extremities: Wide Surgical Resection and Reconstruction without Chemosensitivity
Orthopaedic Oncology & Bone Tumors

Chondrosarcoma of the Pelvis and Extremities: Wide Surgical Resection and Reconstruction without Chemosensitivity

11 min read
Sep 3, 2026
Spica Healthcare Clinical & Surgical Protocol Illustration #104

Clinical Summary & Key Takeaways

An authoritative orthopaedic surgical oncology review on primary malignant cartilage-producing bone tumors (Chondrosarcoma), detailing histologic grading (Grade 1 vs 2/3 vs Dedifferentiated), pelvic internal hemipelvectomy, computerized navigation, and why radical R0 surgery remains the sole curative modality.

CRITICAL CLINICAL RED FLAG: Any expanding, deep, dull bony ache or palpable rock-hard mass in the pelvis, proximal femur, or ribs in an adult over 40 displaying "popcorn" or "rings-and-arcs" calcifications on plain radiography mandates urgent specialist orthopaedic oncology evaluation.

1. Pathology & Histological Grading: The Key to Biological Behavior

Chondrosarcomas represent the second most common primary malignant bone tumor in adults. Characterized by the production of chondroid matrix, their biological behavior varies dramatically across histological subtypes:

  • Grade 1 (Atypical Cartilaginous Tumor): Locally aggressive with virtually zero metastatic risk; select extremity lesions may be managed with extended intralesional curettage and cryotherapy.

  • Grade 2 & 3 Conventional Chondrosarcoma: Highly aggressive with 15–50% metastatic potential (predominantly lungs); mandates radical wide en-bloc resection with clear margins.

  • Dedifferentiated Chondrosarcoma: A devastating biphasic tumor where low-grade cartilage abruptly transforms into high-grade osteosarcoma or undifferentiated pleomorphic sarcoma.

2. Diagnostic Imaging: Cross-Sectional MRI & CT Matrix Mapping

High-resolution contrast MRI delineates intraosseous marrow replacement, lobular hyperintensity on T2-weighted sequences, and soft tissue extraosseous expansion. Thin-slice CT confirms cortical endosteal scalloping >2/3 cortical thickness, periosteal breach, and calcified matrix.

"Because chondrosarcoma produces abundant hyaline extracellular matrix lacking adequate vascularity, it is fundamentally chemo- and radio-resistant; complete 3D surgical extirpation is the patient's only chance for cure." — Dr. Deepak Garg
Spica Healthcare Clinical & Surgical Protocol Illustration #104
Spica Healthcare Clinical & Surgical Protocol Illustration #104

3. Pelvic Internal Hemipelvectomy & Modular Reconstruction

Pelvic chondrosarcomas (Enneking Zones I, II, III, and IV) represent the greatest surgical challenge:

  1. Internal Hemipelvectomy: En-bloc resection of the ilium, periacetabular socket, or pubic rami while preserving the femoral nerve, sciatic nerve, and lower extremity.

  2. 3D-Printed Custom Titanium Pelvic Implants: Computer-navigated osteotomy guides ensure sub-millimeter margin accuracy and immediate anatomical restoration of the hip center of rotation.

  3. Modular Saddle & Cone Megaprostheses: Provide biomechanical stability, allowing full weight-bearing recovery within 8 to 12 weeks.

CLINICAL CAUTION: Intralesional curettage of Grade 2 or 3 Chondrosarcoma carries a devastating local recurrence rate exceeding 70%; wide en-bloc margin clearance is strictly required.

4. Novel Targeted Frontiers: IDH1/IDH2 Inhibitors

Up to 50% of conventional and dedifferentiated chondrosarcomas harbor somatic mutations in Isocitrate Dehydrogenase 1 or 2 (IDH1/IDH2). Targeted small-molecule inhibitors (Ivosidenib) are actively entering clinical trials for unresectable metastatic cases.

5. Peer-Reviewed References & Clinical Guidelines

1. Surgical management of pelvic chondrosarcoma: Functional and oncological outcomes of 150 consecutive cases — Bone Joint J, 2021; 103-B(7): 1290-1300.

2. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer (Version 1.2024) — National Comprehensive Cancer Network, 2024.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.